AAV-RhoA shRNA decreased RhoA expression and promoted neurite outgrowth in vitro. AAV-CNTF promoted RGC survival and axonal regeneration in vivo. AAV-RhoA shRNA alone has weak effects on axonal regeneration in vivo. AAV-RhoA shRNA improved therapeutic effect of AAV-CNTF by two fold in combination.